One-pot multicomponent synthesis of novel pyridine derivatives for antidiabetic and antiproliferative activities

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Sourav DE, Niranjan BM, Suneel BT et al. A review article on importance of heterocyclic compounds. Mintage J. Pharm. Med. Sci. 5(2), 18–27 (2016).
  Google Scholar
• 2. Vitaku E, Smith DT, Njardarson JT. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals. J. Med. Chem. 57, 10257–10274 (2014).
  Medline CASGoogle Scholar
• 3. Campaigne E. Adrien Albert and the rationalization of heterocyclic chemistry. J. Chem. Educ. 63(10), 860–871 (1986). • Discusses scaffold-based rational drug design.
  CASGoogle Scholar
• 4. Landriscina M, Fabiano A, Lombardi V et al. Nevirapine toxicity in non-HIV cancer patients. Chemotherapy 54(6), 475–478 (2008).
  Medline CASGoogle Scholar
• 5. Brown AM, Patch TL, Kaumann AJ. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HTIC receptor agonists in piglet choroid plexus. Br. J. Pharmacol. 104(01), 45–48 (1999).
  Google Scholar
• 6. Hassan F, El-Hiti GA, Abd-Allateef M, Yousif E. Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cell. Saudi Med. J. 38(4), 359–364 (2017). • Discusses scaffold-based rational drug design.
  MedlineGoogle Scholar
• 7. Greer ND. Posaconazole (noxafil): a new triazole antifungal agent. Proc. Bayl. Univ. Med. Cent. 20(2), 188–196 (2007).
  MedlineGoogle Scholar
• 8. Boswell FJ, Andrews JM, Wise R, Dalhoff A. Bactericidal properties of moxifloxacin and post-antibiotic effect. J. Antimicrob. Chemother. 43(2), 43–49 (1999).
  Medline CASGoogle Scholar
• 9. Saravolatz L, Manzor O, Check C, Pawlak J, Belian B. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae. J. Antimicrob. Chemother. 47(6), 875–877 (2001).
  Medline CASGoogle Scholar
• 10. De La Torre-Iglesias PM, Garcia-Rodriguez JJ, Torrado G, Torrado S, Torrado-Santiago S, Bolas-Fernandez F. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropyl cellulose. Drug Des. Devel Ther. 8, 14–67 (2014).
  Google Scholar
• 11. Joule JA, Mills KTE. Heterocyclic Chemistry (5th Edition). Blackwell Publishing, Chichester, UK (2020).
  Google Scholar
• 12. Sherrod TR, Loew ER, Schloemer HF. Pharmacological properties of antihistamine drugs, benadryl, pyribenzamine and neoantergan. J. Pharmacol. Exp. Ther. 89(3), 247–255 (1947).
  Medline CASGoogle Scholar
• 13. Weissberger A, Klingberg A, Barnes RA, Brody F, Ruby PR. Pyridine and its derivatives. New York: Interscience 01 (1960). www.wiley.com/en-gb/Pyridine+and+Its+Derivatives,+Volume+14,+Part+1-p-9780470379172
  Google Scholar
• 14. Supavilai P, Karobath M. Action of pyrazolopyridines as modulators of [3H]flunitrazepam binding to the gaba/benzodiazepine receptor complex of the cerebellum. Eur. J. Pharmacol. 70(02), 183–193 (1981).
  Medline CASGoogle Scholar
• 15. Leeb-Lundberg F, Snowman A, Olsen R. Perturbation of benzodiazepine receptor binding by pyrazolopyridines involves picrotoxinin/barbiturate receptor sites. J. Neurosci. 01(05), 471–477 (1981). • Discusses scaffold-based rational drug design.
  CASGoogle Scholar
• 16. De Jonge M, Koymans L, Guillemont J, Koul A, Andries K. A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. Proteins 67(04), 971–980 (2007).
  MedlineGoogle Scholar
• 17. Ahmad N, Ahuja SD, Akkerman OW et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet 392(10150), 821–834 (2018).
  MedlineGoogle Scholar
• 18. Firke S, Firake B, Chaudhari R, Patil V. Synthetic and pharmacological evaluation of some pyridine containing thiazolidinones. Asian J. Res. Chem. 2(02), 157–161 (2009). • Discusses scaffold-based rational drug design.
  CASGoogle Scholar
• 19. Chavan V, Sonawane S, Shingare M, Karale B. Synthesis, characterization, and biological activities of some 3,5,6-trichloropyridine derivatives. Chem. Heterocyc. Compd. 42, 625–630 (2006). •• Focuses on synthesis, design and modeling of new inhibitors.
  CASGoogle Scholar
• 20. Nassar E. Synthesis, (in vitro) antitumor and antimicrobial activity of some pyrazoline, pyridine, and pyrimidine derivatives linked to indole moiety. J. Am. Sci. 6(8), 338–347 (2010). •• Focuses on synthesis, design and modeling of new inhibitors.
  Google Scholar
• 21. Worachartcheewan A, Prachayasittikul S, Pingaew R et al. Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio-derivatives of 3-picoline and phenylpyridines. Med. Chem. Res. 21, 3514–3522 (2012). •• Focuses on synthesis, design and modeling of new inhibitors.
  CASGoogle Scholar
• 22. Nigade G, Chavan P, Deodhar M. Synthesis and analgesic activity of new pyridine-based heterocyclic derivatives. Med. Chem. Res. 21, 27–37 (2012).
  CASGoogle Scholar
• 23. Sondhi SM, Dinodia M, Kumar A. Synthesis, anti-inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives. Bioorg. Med. Chem. 14(13), 4657–4663 (2006).
  Medline CASGoogle Scholar
• 24. Acharya BN, Thavaselvam D, Kaushik MP. Synthesis and antimalarial evaluation of novel pyridinequinoline hybrids. Med. Chem. Res. 17, 487–494 (2008).
  Google Scholar
• 25. Neelum B, Shailendra, Mt GG et al. Synthesis, characterization and antiamoebic activity of benzimidazole derivatives and their vanadium and molybdenum complexes. Bioorg. Med. Chem. Lett. 12(6), 869–871 (2000).
  Google Scholar
• 26. Abele E, Abele R, Lukevics E. Pyridine oximes: synthesis, reactions, and biological activity. Chem. Heterocyc. Compd. 39, 825–865 (2003).
  CASGoogle Scholar
• 27. El-Hawash SaM, Wahab AEA, El-Demellawy MA. Cyanoacetic acid hydrazones of 3-(and 4-)acetylpyridine and some derived ring systems as potential antitumor and anti-HCV agents. Arch. Pharm. 339(1), 14–23 (2006).
  Medline CASGoogle Scholar
• 28. Jo SU, Gang SG, Kim SS, Jeon HG, Choe JG, Yeom EG. Synthesis and SAR of benzimidazole derivatives containing oxycyclic pyridine as a gastric H⁺/K⁺-ATPase inhibitors. Bull. Korean Chem. Soc. 22(11), 1217–1223 (2001).
  Google Scholar
• 29. Tb C, Dr R. Interactions of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class of chelators with iron and DNA: implications for toxicity in the treatment of iron overload disease. J. Biol. Inorg. Chem. 8, 427–438 (2003).
  MedlineGoogle Scholar
• 30. Kita E, Lisiak R. Potential biochromium sources; kinetic studies on acid- and base-catalyzed aquation of [Cr(ox)₂(2-(aminomethyl)pyridine]. Transition Met. Chem. 35(4), 441–450 (2010).
  CASGoogle Scholar
• 31. Esposito R, Raucci U, Cucciolito ME et al. Iron(III) complexes for highly efficient and sustainable ketalization of glycerol: a combined experimental and theoretical study. ACS Omega 4(1), 688–698 (2019).
  Medline CASGoogle Scholar
• 32. Mattos C, Ringe D. Locating and characterizing binding sites on biacore.com/lifesciences/products/systems_overview/A100/ proteins. Nat. Biotechnol. 14, 595–599 (1996).
  Medline CASGoogle Scholar
• 33. Seth PP, Miyaji A, Jefferson EA et al. SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. J. Med. Chem. 48(23), 7099–7102 (2005).
  Medline CASGoogle Scholar
• 34. Clark M, Guarnieri F, Shkurko I, Wiseman J. Grand canonical Monte Carlo simulation of ligand-protein binding. J. Chem. Inf. Model. 46(1), 231–242 (2006).
  Medline CASGoogle Scholar
• 35. Wr M. Maximizing discovery efficiency with a computationally driven fragment approach.biophysical methods. Curr. Opin. Drug Discov. Devel. 8, 355–364 (2006).
  Google Scholar
• 36. Jung D, Floyd J, Gund TM. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands. J. Comput. Chem. 25(11), 1385–99 (2004).
  Medline CASGoogle Scholar
• 37. Datar PA, Coutinho EC. A CoMFA study of COX-2 inhibitors with receptor based alignment. J. Mol. Graph Model. 23(3), 239–51 (2004).
  Medline CASGoogle Scholar
• 38. Li W-Y, Ma Y, Li H-X et al. Scaffold-based selective SHP2 inhibitors design using core hopping, molecular docking, biological evaluation and molecular simulation. Bioorg. Chem. 105(104391), 1–13 (2020). •• Focuses on synthesis, design and modeling of new inhibitors.
  Google Scholar
• 39. Xin X, Wang Y, Kumar S, Liu X, Lin Y, Dong D. Efficient one-pot synthesis of substituted pyridines through multicomponent reaction. Org. Biomol. Chem. 8, 3078–3082 (2010).
  Medline CASGoogle Scholar
• 40. El-Lateef HMA, Abdelhamid AA, Khalaf MM et al. Green synthesis of novel pyridines via one-pot multicomponent reaction and their anti-inflammatory evaluation. ACS Omega 8(12), 11326–11334 (2023).
  MedlineGoogle Scholar
• 41. Zareen G, Shafiq N, Arshad U, Rafiq N, Parveen S, Ahmad Z. Copper-catalyzed one-pot relay synthesis of anthraquinone based pyrimidine derivative as a probe for antioxidant and antidiabetic activity. J. Mol. Struct. 1227, 129668 (2021).
  Google Scholar
• 42. Arshad U, Ahmed S, Shafiq N et al. Structure-based designing, solvent less synthesis of 1,2,3,4-tetrahydropyrimidine-5-carboxylate derivatives: a combined in vitro and in silico screening approach. Molecules 26(15), 4424 (2021).
  Medline CASGoogle Scholar
• 43. Dineshkumar B, Mitra A, Manjunatha M. A comparative study of alpha amylase inhibitory activities of common anti-diabetic plants at Kharagpur 1 block. Int. J. Green Pharm. 4(2), 115–121 doi:10.22377/ijgp.v4i2.131 (2010).
  Google Scholar
• 44. Selvarasu S, Srinivasan P, Mannathusamy G, Susai BMJCDC. Synthesis, characterization, in silico molecular modeling, anti-diabetic and antimicrobial screening of novel 1-aryl-N-tosyl-1H-tetrazole-5-carboxamide derivatives. Chemical Data Collections 32, 100648 (2021).
  CASGoogle Scholar
• 45. Arshad U, Ahmed S, Shafiq N et al. Structure-based designing, solvent less synthesis of 1,2,3,4-tetrahydropyrimidine-5-carboxylate derivatives: a combined in vitro and in silico screening approach. Molecules 26(15), 4424 (2021).
  Medline CASGoogle Scholar
• 46. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160(2), 171–177 (2006).
  Medline CASGoogle Scholar
• 47. Riss TL, Moravec RA, Niles AL et al. Cell viability assays. In: Assay Guidance Manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences (2016). www.ncbi.nlm.nih.gov/books/NBK144065/
  Google Scholar
• 48. Singla RK, He X, Chopra H et al. Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources. Frontiers in Pharmacology 3215 (2021).
  Google Scholar
• 49. Pamuru RR, Ponneri N, Damu AG, Vadde R. Targeting Natural Products for the Treatment of COVID-19-An Updated Review. Current Pharmaceutical Design 26, 5278–5285 (2020).
  Medline CASGoogle Scholar
• 50. Kataria R, Khatkar A. In-silico design, synthesis, ADMET studies and biological evaluation of novel derivatives of chlorogenic acid against urease protein and H. pylori bacterium. BMC Chemistry 13(1), 1–17 (2019).
  MedlineGoogle Scholar
• 51. Taha M, Noreen T, Imran S et al. Synthesis, α-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives. Medicinal Chemistry Research 28(11), 2010–2022 (2019).
  CASGoogle Scholar
• 52. Yousuf H, Shamim S, Khan KM et al. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: synthesis, in vitro and in silico studies. Bioorg Chem. 96, 103581 (2020).
  Medline CASGoogle Scholar
• 53. Fan N, Zhang S, Sheng T et al. Docking field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptase. Chem. Biol. Drug Des. 91(2), 398–407 (2018).
  Medline CASGoogle Scholar
• 54. Mahmud S, Uddin MaR, Zaman M et al. Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2. J. Biomol. Struct. Dyn. 39(16), 6281–6289 (2020).
  MedlineGoogle Scholar
• 55. Sharma K, Morla S, Goyal A, Kumar S. Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2. Life Sciences 259, 118169 (2020).
  Medline CASGoogle Scholar
• 56. Yanuar A, Pratiwi I, Syahdi RR. In silico activity analysis of saponins and 2,5-piperazinedione from marine organism against murine double minute-2 inhibitor and procaspase-3 activator. Journal of Young Pharmacists 10(2), S16-S19 (2018).
  Google Scholar
• 57. Zhao B, Zhao C, Hu X et al. Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and HeLa cancer cells. European Journal of Medicinal Chemistry 185, 111809 (2020).
  Medline CASGoogle Scholar
• 58. Liew SK, Malagobadan S, Arshad NM, Nagoor NH. A review of the structure–activity relationship of natural and synthetic antimetastatic compounds. Biomolecules 10(1), 138 (2020).
  Medline CASGoogle Scholar
• 59. Liu L, Ma H, Yang N, Tang Y, Guo J, Tao W. A series of natural flavonoids as thrombin inhibitors: structure–activity relationships. Thromb Res. 126(5), e365–e378 (2010).
  Medline CASGoogle Scholar
• 60. Bouchagra S, Benamia F, Djeghaba Z. Docking studies of (-)-epigallocatechin-3-gallate: a potential non-competitive pancreatic lipase inhibitor. Research Journal of Pharmaceutical, Biological and Chemical Sciences 7(5), 2493–2505 (2016).
  CASGoogle Scholar
• 61. Zulqurnain M, Fahmi MRG, Fadlan A, Santoso M. Synthesis and molecular docking study of pyrazine-2-carboxylic acid derivatives. Presented at: IOP Conference Series: Materials Science and Engineering. Institut Teknologi Sepuluh Nopember Universitas Ma Chung (2020). https://scholar.its.ac.id/en/publications/synthesis-and-molecular-docking-study-of-pyrazine-2-carboxylic-ac/fingerprints/
  Google Scholar
• 62. Abdel-Rahman LH, Abu-Dief AM, Shehata MR, Atlam FM, Abdel-Mawgoud AAH. Some new Ag(I), VO(II) and Pd(II) chelates incorporating tridentate imine ligand: design, synthesis, structure elucidation, density functional theory calculations for DNA interaction, antimicrobial and anticancer activities and molecular docking studies. Applied Organometallic Chemistry 33(4), e4699 (2019).
  Google Scholar
• 63. Ashok D, Devulapally MG, Aamate VK et al. Novel pyrano [3,2-b] xanthen-7 (2H)-ones: synthesis, antimicrobial, antioxidant and molecular docking studies. Journal of Molecular Structure 1177, 215–228 (2019).
  CASGoogle Scholar
• 64. Kousar K, Majeed A, Yasmin F, Hussain W, Rasool N. Phytochemicals from selective plants have promising potential against SARS-CoV-2: investigation and corroboration through molecular docking, MD simulations, and quantum computations. BioMed Research International 2020, 1–15 (2020).
  Google Scholar
• 65. Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A. Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study. Mar. Drugs 18(4), 225 (2020).
  Medline CASGoogle Scholar
• 66. Crisan L, Istrate D, Bora A, Pacureanu L. Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson’s disease treatment. Mol Divers. 25(3), 1–20 (2020).
  MedlineGoogle Scholar
• 67. Corbeil CR, Williams CI, Labute P. Variability in docking success rates due to dataset preparation. J. Comput. Aided Mol Des. 26(6), 775–786 (2012).
  Medline CASGoogle Scholar
• 68. Gouda AM, Almalki FA. Carprofen: a theoretical mechanistic study to investigate the impact of hydrophobic interactions of alkyl groups on modulation of COX-1/2 binding selectivity. SN Applied Sciences 1(4), 332 (2019).
  CASGoogle Scholar
• 69. Horchani M, Hajlaoui A, Harrath AH, Mansour L, Jannet HB, Romdhane A. New pyrazolo-triazolo-pyrimidine derivatives as antibacterial agents: design and synthesis, molecular docking and DFT studies. J. Mol. Struct. 1199, 127007 (2020).
  CASGoogle Scholar
• 70. Shkir M, Irfan A, Alfaify S, Patil PS, Al-Sehemi AG. Linear, second and third order nonlinear optical properties of novel noncentrosymmetric donor-acceptor configure chalcone derivatives: a dual approach study. Optik 199, 163354 (2019).
  CASGoogle Scholar
• 71. Maidur SR, Patil PS, Ekbote A, Chia TS, Quah CK. Molecular structure, second-and third-order nonlinear optical properties and DFT studies of a novel non-centrosymmetric chalcone derivative:(2E)-3-(4-fluorophenyl)-1-(4-{[(1E)-(4-fluorophenyl)methylene]amino}phenyl) prop-2-en-1-one. Spectrochim. Acta A Mol. Biomol. Spectrosc. 184, 342–354 (2017).
  Medline CASGoogle Scholar
• 72. Touafri L, Hellal A, Chafaa S, Khelifa A, Kadri A. Synthesis, characterisation and DFT studies of three Schiff bases derived from histamine. J. Mol. Struct. 1149, 750–760 (2017).
  CASGoogle Scholar
• 73. Frisch A, Dennington I, Keith T et al. Reference, Version 4.0, Gaussian Inc. Inc Pittsburgh. (2007).
  Google Scholar
• 74. Van Mourik T, Bühl M, Gaigeot M-P. Density functional theory across chemistry, physics and biology. Philos. Trans. A Math. Phys. Eng. Sci. 372(2011), 20120488 (2014).
  MedlineGoogle Scholar
• 75. Kerru N, Gummidi L, Bhaskaruni SV, Maddila SN, Singh P, Jonnalagadda SB. A comparison between observed and DFT calculations on structure of 5-(4-chlorophenyl)-2-amino-1,3,4-thiadiazole. Sci. Rep. 9(1), 19280 (2019).
  Medline CASGoogle Scholar
• 76. Alaşalvar C, Soylu MS, Ünver H et al. Crystal structure and DFT calculations of 5-(4-chlorophenyl)-1-(6-methoxypyridazin-3-yl)-1H-pyrazole-3-carboxylic acid. Spectrochim. Acta A Mol. Biomol. Spectrosc. 132, 555–562 (2014).
  Medline CASGoogle Scholar
• 77. Kozyra P, Kaczor A, Karczmarzyk Z, Wysocki W, Pitucha M. Experimental and computational studies of tautomerism pyridine carbonyl thiosemicarbazide derivatives. Struct. Chem. 34(1), 1–12 (2023).
  Google Scholar
• 78. Pierens GK, Venkatachalam T, Reutens DC. NMR and DFT investigations of structure of colchicine in various solvents including density functional theory calculations. Sci. Rep. 7(1), 5605 (2017).
  MedlineGoogle Scholar
• 79. Chugunova E, Micheletti G, Telese D et al. Novel hybrid compounds containing benzofuroxan and aminothiazole scaffolds: synthesis and evaluation of their anticancer activity. Int. J. Mol. Sci. 22(14), 7497 (2021).
  Medline CASGoogle Scholar
• 80. Pávez P, Encinas MV. Photophysics and photochemical studies of 1,4-dihydropyridine derivatives. Photochem. Photobiol. 83(3), 722–729 (2007).
  Medline CASGoogle Scholar
• 81. Mamatha S, Bhat M, Kumara H, Gowda DC, Tirukoti M, Meenakshi S. Design, synthesis and SAR evaluation of mercaptooxadiazole analogs as anti-tubercular, anti-diabetic and anti-bacterial agents. Chemical Data Collections 26, 100343 (2020).
  CASGoogle Scholar
• 82. Mohamed EA, Ismail NS, Hagras M, Refaat H. Medicinal attributes of pyridine scaffold as anticancer targeting agents. Future Journal of Pharmaceutical Sciences 7(1), 1–17 (2021).
  Google Scholar
• 83. Gati W, Rammah MM, Rammah MB, Couty F, Evano G. De novo synthesis of 1,4-dihydropyridines and pyridines. JACS 134(22), 9078–9081 (2012).
  Medline CASGoogle Scholar
• 84. Wójcicka A, Redzicka AJP. An overview of the biological activity of pyrrolo [3,4-c] pyridine derivatives. Pharmaceuticals (Basel) 14(4), 354 (2021).
  Medline CASGoogle Scholar
• 85. Lee HW, Kim BY, Ahn JB et al. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione. Eur. J. Med. Chem. 40(9), 862–874 (2005).
  Medline CASGoogle Scholar
• 86. Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P et al. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic, and docking study. Bioorganic Chemistry 83, 161–169 (2018).
  MedlineGoogle Scholar
• 87. Ramya V, Vembu S, Ariharasivakumar G, Gopalakrishnan M. Synthesis, characterisation, molecular docking, anti-microbial and anti-diabetic screening of substituted 4-indolylphenyl-6-arylpyrimidine-2-imine derivatives. Drug Res (Stuttg). 67(09), 515–526 (2017).
  Medline CASGoogle Scholar
• 88. Hu Y, Wang B, Yang J et al. Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents. J. Enzyme Inhib. Med. Chem. 34(1), 15–30 (2019).
  Medline CASGoogle Scholar
• 89. Paul A, Hazra S, Guedes da Silva MFC, Pombeiro AJL. Biological evaluation of azo-and imino-based carboxylate triphenyltin(IV) compounds. European Journal of Inorganic Chemistry 2020(11–12), 930–941 (2020).
  CASGoogle Scholar
• 90. Kamal A, Reddy JS, Ramaiah MJ et al. Design, synthesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents. MedChemComm 1(5), 355–360 (2010).
  CASGoogle Scholar
• 91. Lazze M, Pizzala R, Savio M, Stivala L, Prosperi E, Bianchi L. Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutat. Res. 535(1), 103–115 (2003).
  Medline CASGoogle Scholar
• 92. Mor S, Sindhu SJ. Synthesis, type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno [1,2-c] pyrazol-4 (1H)-ones. Med Chem Res. 29(1), 46–62 (2020).
  Medline CASGoogle Scholar
• 93. Jadhav NC, Pahelkar AR, Desai NV, Telvekar VN. Design, synthesis and molecular docking study of novel pyrrole-based α-amylase and α-glucosidase inhibitors. Medicinal Chemistry Research 26(10), 2675–2691 (2017).
  CASGoogle Scholar
• 94. Toumi A, Boudriga S, Hamden K et al. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors. Bioorganic Chemistry 106, 104507 (2021).
  Medline CASGoogle Scholar
• 95. Mokenapelli S, Thalari G, Vadiyaala N et al. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles. Archiv der Pharmazie. 353(6), 2000006 (2020).
  CASGoogle Scholar
• 96. Abd El-Aleam RH, George RF, Hassan GS, Abdel-Rahman HM. Synthesis of 1,2,4-triazolo [1,5-a] pyrimidine derivatives: Antimicrobial activity, DNA Gyrase inhibition and molecular docking. Bioorg Chem. 94, 103411 (2020).
  MedlineGoogle Scholar
• 97. Modi P, Patel S, Chhabria MT. Identification of some novel pyrazolo [1,5-a] pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking. J. Biomol. Struct. Dyn. 37(7), 1736–1749 (2019).
  Medline CASGoogle Scholar
• 98. López-Camacho E, García-Godoy MJ, García-Nieto J, Nebro AJ, Aldana-Montes JF. A new multi-objective approach for molecular docking based on RMSD and binding energy. Presented at: International Conference on Algorithms for Computational Biology. (2016). https://link.springer.com/chapter/10.1007/978-3-319-38827-4_6
  Google Scholar
• 99. Adiguzel R, Aktan E, Evren E, Çetin A. A computational study on some pyridine-substituted-bis-1,2,4-triazole derivatives and investigation of their catalytic activities. Int. J. Pure Appl. Sci. 6(2), 200–207 (2020).
  Google Scholar
• 100. Naik IK, Bodapati R, Sarkar R, Mondal N, Das SK. Functional molecular system of bis (pyrazolyl) pyridine derivatives: photophysics, spectroscopy, computation, and ion sensing. ACS Omega 3(3), 3022–3035 (2018).
  Medline CASGoogle Scholar
• 101. Sayin K, Üngördü A. Investigation of anticancer properties of caffeinated complexes via computational chemistry methods. Spectrochim. Acta A Mol. Biomol. Spectrosc. 193, 147–155 (2018).
  Medline CASGoogle Scholar
• 102. Naseem S, Khalid M, Tahir MN et al. Synthesis, structural, DFT studies, docking and antibacterial activity of a xanthene based hydrazone ligand. J. Mol. Struct. 1143, 235–244 (2017).
  CASGoogle Scholar
• 103. Zarrouk A, Hammouti B, Lakhlifi T, Traisnel M, Vezin H, Bentiss F. New 1H-pyrrole-2, 5-dione derivatives as efficient organic inhibitors of carbon steel corrosion in hydrochloric acid medium: electrochemical, XPS and DFT studies. Corros. Sci. 90, 572–584 (2015).
  CASGoogle Scholar
• 104. Jawaria R, Hussain M, Khalid M et al. Synthesis, crystal structure analysis, spectral characterization and nonlinear optical exploration of potent thiosemicarbazones based compounds: a DFT refine experimental study. Inorg. Chim. Acta. 486, 162–171 (2019).
  CASGoogle Scholar
• 105. Kulabaş N, Tatar E, Özakpınar ÖB et al. Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio) acetamide derivatives as inducers of apoptosis in cancer cells. Eur. J. Med. Chem. 121, 58–70 (2016).
  Medline CASGoogle Scholar
• 106. Salgın-Gökşen U, Gökhan-Kelekçi N, Göktaş Ö et al. 1-Acylthiosemicarbazides, 1,2,4-triazole-5 (4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg. Med. Chem. 15(17), 5738–5751 (2007).
  MedlineGoogle Scholar
• 107. Rachedi KO, Ouk T-S, Bahadi R et al. Synthesis, DFT and POM analyses of cytotoxicity activity of α-amidophosphonates derivatives: identification of potential antiviral O,O-pharmacophore site. J. Mol. Struct. 1197, 196–203 (2019).
  CASGoogle Scholar
• 108. Hussain A, Khan MU, Ibrahim M et al. Structural parameters, electronic, linear and nonlinear optical exploration of thiopyrimidine derivatives: a comparison between DFT/TDDFT and experimental study. J. Mol. Struct. 1201, 127183 (2020).
  Google Scholar
• 109. Azam F, Alabdullah NH, Ehmedat HM, Abulifa AR, Taban I, Upadhyayula S. NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies. J. Biomol. Struct. Dyn. 36(8), 2099–2117 (2018).
  Medline CASGoogle Scholar
• 110. Obot I, Kaya S, Kaya C, Tüzün B. Density functional theory (DFT) modeling and Monte Carlo simulation assessment of inhibition performance of some carbohydrazide Schiff bases for steel corrosion. Physica E 80, 82–90 (2016).
  CASGoogle Scholar
• 111. Sagaama A, Brandan SA, Issa TB, Issaoui N. Searching potential antiviral candidates for the treatment of the 2019 novel coronavirus based on DFT calculations and molecular docking. Heliyon 6(8), e04640 (2020).
  MedlineGoogle Scholar